Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:27 PM
Study NCT ID:
NCT03409458
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2018-01-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
Sponsor:
Promontory Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-18
First Submit QC Date:
None
Study First Post Date:
2018-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-15
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL